This study aimed to assess a possible association between circulating leptin levels and ultrasound metrics of liver steatosis and fibrosis, measured with FibroScan, in a cohort of individuals that are overweight or obese and free from concomitant chronic comorbidities and pharmacological treatments. Here, LEP is linked to fatty liver disease.